Rinkin, C., Malaise, O., Lamaye, C., CHAUVEHEID, F., GERARD, C., Seidel, L., Malaise, M., Hustinx, R., & Ribbens, C. (October 2025). 18F-FDG PET/CT discriminates whether rheumatoid arthritis patients are in ultrasound remission or not. Rheumatology Advances in Practice, 9 (4), 125. doi:10.1093/rap/rkaf125 |
Malaise, O., Rinkin, C., GERARD, C., CHAUVEHEID, F., Seidel, L., Malaise, M., & Ribbens, C. (28 June 2025). Ultrasound- and clinical-defined disease activities are associated with altered bone microarchitecture and lower bone mineral density in patients with rheumatoid arthritis. Aging Clinical and Experimental Research, 37 (1), 199. doi:10.1007/s40520-025-03105-5 |
Rinkin, C., Malaise, O., CHAUVEHEID, F., GERARD, C., Seidel, L., Malaise, M., & Ribbens, C. (07 May 2024). Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis. BMC Musculoskeletal Disorders, 25 (1), 361. doi:10.1186/s12891-024-07472-4 |
CHAUVEHEID, F., Von Frenckell, C., Colin, G., DEFLANDRE, E., Piette, Y., Duysinx, B., Bianchi, E., Malaise, M., & Malaise, O. (July 2022). Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1. Revue Médicale de Liège, 77 (7-8), 462-467. |